Spots Global Cancer Trial Database for oncolytic
Every month we try and update this database with for oncolytic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer | NCT02705196 | Pancreatic Canc... | delolimogene mu... gemcitabine nab-paclitaxel atezolizumab | 18 Years - | Lokon Pharma AB | |
A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis | NCT01443260 | Peritoneal Carc... | GL-ONC1 | 18 Years - | Genelux Corporation | |
Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma | NCT00769704 | Melanoma | Talimogene lahe... GM-CSF | 18 Years - | BioVex Limited | |
An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma | NCT01368276 | Melanoma | Talimogene Lahe... Granulocyte Mac... | 18 Years - | BioVex Limited | |
Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma | NCT00769704 | Melanoma | Talimogene lahe... GM-CSF | 18 Years - | BioVex Limited | |
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer | NCT02705196 | Pancreatic Canc... | delolimogene mu... gemcitabine nab-paclitaxel atezolizumab | 18 Years - | Lokon Pharma AB | |
Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma | NCT00769704 | Melanoma | Talimogene lahe... GM-CSF | 18 Years - | BioVex Limited | |
Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors | NCT00794131 | Advanced Cancer... | GL-ONC1 | 18 Years - | Genelux Corporation | |
Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma | NCT01864759 | Locally Advance... | ICOVIR-5 | 18 Years - | Institut Català d'Oncologia | |
Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy | NCT03171493 | Urothelial Carc... | MV-NIS | 18 Years - | Vyriad, Inc. | |
HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors | NCT02457845 | Supratentorial ... Malignant Gliom... Glioblastoma Anaplastic Astr... PNET Cerebral Primit... Embryonal Tumor | G207 | 3 Years - 18 Years | University of Alabama at Birmingham | |
A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancer | NCT03213054 | Esophageal Canc... | OBP-301 Radiation | 20 Years - 89 Years | Oncolys BioPharma Inc | |
A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancer | NCT03213054 | Esophageal Canc... | OBP-301 Radiation | 20 Years - 89 Years | Oncolys BioPharma Inc |